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Ribosome biogenesis requires an enormous commit-
ment of energy and resources in growing cells. In
budding yeast, the transcriptional coactivator Ifh1p
is an essential regulator of ribosomal protein (RP)
gene transcription. Here, we report that Ifh1p is
dynamically acetylated and phosphorylated as a
function of the growth state of cells. Ifh1p is acety-
lated at numerous sites in its N-terminal region by
Gcn5p and deacetylated by NAD+-dependent deace-
tylases of the sirtuin family. Acetylation of Ifh1p is
responsive to intracellular acetyl-CoA levels and
serves to regulate thestability of Ifh1p.Thephosphor-
ylation of Ifh1p is mediated by protein kinase A and
is dependent on TORC1 signaling. Thus, multiple
nutrient-sensing mechanisms converge on Ifh1p.
However, instead of modulating overall rates of RP
gene transcriptionor cell growth, thenutrient-respon-
sive phosphorylation of Ifh1p plays amore prominent
role in the regulation of cellular replicative lifespan.INTRODUCTION
In the budding yeast Saccharomyces cerevisiae, ribosome
biogenesis is tightly linked to cell growth. The synthesis of new
ribosomes involves transcription of rDNA, ribosomal protein
(RP) genes, and genes encoding accessory factors for rRNA pro-
cessing and ribosome assembly, collectively called ribosome
biogenesis (ribi) genes (Zaman et al., 2008). In rapidly growing
cells, the majority of cellular transcriptional activity is devoted
to ribosome biogenesis (Warner, 1999). This energetically and
resource-intensive process is also essential for cell-cycle entry,
given that an increase in translational capacity is needed to attain
a critical cell mass before commitment to division (Jorgensen
and Tyers, 2004). Although ribosome biogenesis is known to
be regulated by nutrient-sensing signal transduction pathways
such as the target of rapamycin (TOR) and protein kinase A
(PKA) pathways, the precise manner by which key nutritionalCell Recues are relayed to the ribosome biogenesis machinery has
not been fully elucidated (Zaman et al., 2008).
The transcription factor Ifh1p is an essential regulator of RP
genes. This coactivator can be dynamically recruited to RP
gene promoters in response to nutrient availability and interacts
with other transcription factors such as Fhl1p and Rap1p (Martin
et al., 2004; Rudra et al., 2005; Schawalder et al., 2004; Wade
et al., 2004). Ifh1p also forms a complex with the rRNA process-
ing factors Rrp7p, Utp22p, and casein kinases, which have been
termed the CURI complex (Rudra et al., 2007). Hence, Ifh1p
might also regulate rRNA processing.
In this study, we utilized the yeast metabolic cycle (YMC) sys-
tem to investigate the dynamics of ribosome biogenesis at high
temporal resolution. Yeast cells become highly synchronized
and undergo robust oscillations in oxygen consumption during
continuous, glucose-limited growth (Figure 1A). Thesemetabolic
cycles have revealed the changes in gene expression and meta-
bolism that occur as cells transition between different growth
states (Tu et al., 2005; Tu et al., 2007). Each YMC is composed
of three phases: oxidative (OX), reductive building (RB), and
reductive charging (RC) (Figure 1A). The OX phase is character-
ized by increased mitochondrial respiration and rapid induction
of growth genes. Genes involved in ribosome biogenesis (RP
and ribi genes) are almost exclusively expressed during this
phase (Cai et al., 2011). As oxygen consumption decreases, cells
enter the RB phase and turn on cell-cycle genes as they begin
division. In the RC phase, cells express many stress- and sta-
tionary-phase-associated genes and become quiescent-like
(Shi et al., 2010). By sampling cycling cells as they synchronously
transition between these different phases, we identified dynamic
posttranslational modifications of Ifh1p and subsequently char-
acterized their contributions to the regulation of ribosomal
gene transcription, cell growth, and replicative lifespan.
RESULTS
In Addition to Ribosomal Subunit Genes, Several
Translation Factors andMetabolic Genes Are Targets of
Ifh1p
As previously characterized in the YMC, RP gene expression is
induced robustly in the OX growth phase (Tu et al., 2005). Theports 4, 1063–1071, September 26, 2013 ª2013 The Authors 1063
Figure 1. Ifh1p Dynamically Binds to Ribo-
somal Subunit Genes during Growth
(A) RP subunit genes are robustly induced during
OX phase, which is the growth phase of the YMC.
Shown is the expression profile of a representative
RP gene RPS11B over three consecutive meta-
bolic cycles (Tu et al., 2005).
(B) Ifh1p preferentially binds to RP genes during
OX phase. Cells from representative time points at
OX, RB, and RC phases were collected and fixed
for ChIP-PCR. Three primer sets spanning the
promoter region of RPS11B were used in the
analysis of Ifh1p binding. Error bars come from
technical triplicates.
(C) ChIP-seq reveals increased binding of Ifh1p
to RP genes during growth. Genome-wide
occupancy profile of Ifh1-FLAG was obtained
for cells collected from OX (growth) and
RC (G0/quiescent-like) phase of the YMC.
Ifh1p binds to regulatory regions of nearly all
RP genes. Data for two representative RP genes
are shown with CisGenome.
(D) Ifh1p binds to non-RP genes, including
genes involved in metabolism. The ChIP-seq
data were scrutinized visually in order to identify
all putative targets. Non-RP genes, including
several involved in metabolism, are also targets of
Ifh1p. Many of these genes have Ifh1p bound
across the open reading frame instead of at the
promoter.
(E) Ifh1p binds to genes encoding translation
elongation factors.
(F) Ifh1p binds to other non-RP genes, including
GCN4.
See also Figures S1 and S2.association of Ifh1p at the promoters of RP genes is sensitive
to growth conditions in batch culture (Schawalder et al.,
2004; Wade et al., 2004). We tested whether Ifh1p binding at
RP gene promoters is dynamic, given that a function of
changes in the metabolic state experienced by cells during
the YMC. Chromatin immunoprecipitation (ChIP) analysis
confirmed that Ifh1p exhibited increased binding to a RP
gene promoter (RPS11B) in the OX growth phase when
massive RP gene transcription takes place (Figures 1A and
1B). To investigate how Ifh1p occupancy changes on a
genome-wide scale, we conducted ChIP sequencing (ChIP-
seq) experiments with cells collected from the OX, growth
phase, and RC, quiescent-like phase. Peaks called by
CisGenome from OX phase data are listed in Table S1. The1064 Cell Reports 4, 1063–1071, September 26, 2013 ª2013 The Authorsmajority of Ifh1p targets are RP genes,
which is in agreement with previous find-
ings (Wade et al., 2004). Moreover, Ifh1p
binding to RP genes was more apparent
in OX than RC phase (Figure 1C), consis-
tent with the ChIP-PCR data (Figure 1B).
We also manually inspected the ChIP-
seq data to identify putative targets
that might have eluded peak-calling
algorithms. Examination of all 137 RPgenes revealed Ifh1p binding to proximal genomic regions of
every RP gene except RPS28A, RPL4A, RPL4B, RPL1A, and
RPL18B. Interestingly, Ifh1p also displayed binding to several
non-RP genes, including metabolic genes (Figure 1D), transla-
tion factors (Figure 1E), and others such as GCN4, a transcrip-
tion factor regulating amino acid biosynthetic genes (Figure 1F).
Some additional peaks with weak signals are shown (Figure S1).
Unlike peaks at RP genes, which are always at intergenic re-
gions, some of the peaks at non-RP genes span the entire
open reading frame. Moreover, the timing of Ifh1p binding often
corresponded to the timing of the target’s expression (Fig-
ure S2). These data indicate that, in addition to RP genes,
Ifh1p regulates additional targets that are important for cell
growth and metabolism.
Figure 2. Ifh1p Is Dynamically Acetylated and Phosphorylated During Growth
(A) Ifh1p is dynamically acetylated and phosphorylated. Ifh1-FLAG was immunoprecipitated from cells collected across 12 time points of the YMC. Ifh1p is
acetylated during the OX growth phase precisely when acetyl-CoA levels increase. A mobility shift of both the full-length Ifh1-FLAG protein (arrow) and its
cleavage products was observed at time point 6, which is suggestive of phosphorylation.
(B) Ifh1p is phosphorylated. Lysates were prepared from OX and RC phase and treated with or without phosphatase (PPase). A cleavage product of Ifh1p
at 50 KDa is shown. The upshifted band in the OX phase sample was reduced after PPase treatment, indicating the shift was due to phosphorylation.
(C) Phosphorylated Ifh1p is recognized by a PKA substrate-specific antibody. An antibody that recognizes the phospho-PKA substrate motif RRXS*/T* (* denotes
phosphorylation) was used for immunoblotting against Ifh1p. The signal was eliminated after PPase treatment.
(D) Dynamic phosphorylation of Ifh1p. Both acetylation and phosphorylation of Ifh1p increase during the OX, growth phase.
(E) Acetylation of Ifh1p is sensitive to growth state. IFH1-FLAG cells were cultured in SD medium to log phase, and time points were collected as the cells were
grown to a higher OD approaching stationary phase. Note that Ifh1p becomes deacetylated prior to the decrease in its protein level.
(F) The acetylation and phosphorylation of Ifh1p are regulated by TORC1. Cells were grown in YPD to log phase, and treated as indicated for 15 min.
Phosphorylation and acetylation were both inhibited by rapamycin and stimulated by cycloheximide.Ifh1p Is Dynamically Acetylated and Phosphorylated
During Growth Phase
We previously reported that acetyl-CoA, a central metabolite of
carbon sources, drives the cellular transcriptional growth pro-
gram by inducing the acetylation of histones present at growth
genes and the G1 cyclin CLN3 (Cai et al., 2011; Shi and Tu,
2013). This regulatory mechanism was discovered through a
proteomic screen that identified dynamically acetylated compo-
nents of the complex Spt-Ada-Gcn5-acetyltransferase (SAGA)
(Cai et al., 2011). In subsequent validation of candidates, this
screen also revealed Ifh1p to be a dynamically acetylated,
nonhistone protein.Cell ReIfh1p is acetylated precisely in tune with the increase in acetyl-
CoA levels that accompanies entry into the OX growth phase
(Figure 2A). This acetylation of Ifh1p mirrors that of SAGA and
histones, occurring during the same temporal window of the
YMC (Cai et al., 2011). Besides dynamic acetylation, we also
observed a mobility shift of the full-length Ifh1-FLAG protein as
well as its degradation products at a single time point in themidst
of OX phase (Figure 2A) when RP genes are induced. The
upshifted band in OX phase was reduced to the same size as
the band in RC phase after treatment with phosphatase, indi-
cating that the band shift was due to phosphorylation (Figure 2B).
Given that the target of rapamycin complex 1 (TORC1) effectorsports 4, 1063–1071, September 26, 2013 ª2013 The Authors 1065
Figure 3. Ifh1p Is Acetylated by Gcn5p and Deacetylated by Sirtuins
(A) Ifh1-FLAG is acetylated by Gcn5p and deacetylated by Sir2p. Ifh1-FLAG was immunoprecipitated from YPD log phase cells from the indicated strains and
probed with an acK antibody. Acetylation was abolished in a gcn5D strain and increased in sir2D, but not rpd3D, strains. Acetylation was further increased in a
sir2Dhst1D strain.
(B) Ifh1p is deacetylated primarily by Sir2p. Ifh1p acetylation was compared in single-deletion mutants of the SIR2 family.
(C) Ifh1p is deacetylated by Hst1p and Hst2p in the absence of Sir2p. Ifh1p acetylation was compared in double-deletion mutants combining sir2Dwith deletions
in HST genes.
(D) Schematic diagram for cysteine substitution mutants of Ifh1p used for mapping modification sites. Wild-type Ifh1p contains two cysteines. Mutations of C580
and C665 to serine were introduced. Serine-to-cysteine mutations were introduced at the indicated positions. See also Figure S3.
(E) Cleavage of the native form of Ifh1p suggests that acetylation sites are N-terminal to C580. Wild-type Ifh1p was immunoprecipitated from YPD log phase
cultures and subjected to cleavage at cyanylated cysteines. The bands recognized by acK antibody and FLAG antibody are different sizes, suggesting that
acetylation sites are not at fragments C-terminal to the cleavage sites, which are recognized by the FLAG antibody.
(F) The aa 189–297 region of Ifh1p contains acetylation sites. On the basis of a similar logic, it can be deduced that Ifh1p is acetylated between residues 189–297.
Cycloheximide (CHX), which stimulates TORC1 signaling, generates the same pattern as the nontreated group.
(G) Mutation of 18 lysines in the aa 189–297 region only slightly decreased the acetylation of Ifh1p. K to R mutations were introduced in order to eliminate the
lysines that can be acetylated in the above mapped region. Although acetylation was decreased, Ifh1p is still significantly acetylated.
(H) Mutation of 39 lysines in the aa 1–297 region eliminates the acetylation of Ifh1p. An additional 21 lysines before S189 were mutated, eliminating the residual
acetylation on Ifh1p. CHX treatment did not result in any observable acetylation of this Ifh1p 39K/R mutant.
(legend continued on next page)
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Sch9p and PKA have been linked to the ribosome biogenesis
program (Zaman et al., 2008) and the substrate motif for these
kinases is known to be RRXS/T, we tested whether the phos-
phorylation of Ifh1p could be detected by an antibody that spe-
cifically recognizes the phosphorylated serine or threonine in
RRXS/T motifs (Figure 2C). This antibody recognized the phos-
phorylated form of Ifh1p but did not recognize it after phospha-
tase treatment, confirming that it is likely a substrate of this family
of kinases. Then, we verified that Ifh1p is dynamically phosphor-
ylated in the YMC specifically during the OX growth phase when
ribosomal genes are activated (Figure 2D). Thus, using the YMC,
we observed that Ifh1p is subjected to both acetylation and
phosphorylation modifications, which specifically occur during
growth phase.
Posttranslational Modifications of Ifh1p Are Sensitive to
Nutrient Cues and Regulated by TORC1
Then, we investigated these dynamic modifications on Ifh1p
under typical batch culture conditions. In synthetic dextrose
(SD) minimal medium, protein levels of Ifh1p decreased substan-
tially as cells entered the stationary phase (Figure 2E). However,
the acetylation of Ifh1p began to decrease prior to the decrease
in Ifh1p protein levels, consistent with the idea that this modifica-
tion is sensitive to nutrient state (Figure 2E). Given that TORC1
signaling has been shown to play key roles in nutrient sensing
and ribosome biogenesis (Martin et al., 2004; Zaman et al.,
2008), we tested whether posttranslational modifications of
Ifh1p might be regulated by TORC1. To modulate TORC1
signaling, we used either rapamycin to inhibit TORC1 activity
or cycloheximide, a translation elongation inhibitor that has
been reported to stimulate TORC1 signaling (Huber et al.,
2009). We observed that both the acetylation and phosphoryla-
tion of Ifh1p were strongly inhibited by rapamycin treatment. In
contrast, these modifications were stimulated by cycloheximide
(Figure 2F). Altogether, these data indicate that TORC1 can regu-
late the dynamic acetylation and phosphorylation of Ifh1p.
Ifh1p Is Acetylated in Its N-Terminal Region by Gcn5p
and Deacetylated by Sirtuins
Substrates of Gcn5p-containing SAGA appear to be dynamically
acetylated in tune with intracellular acetyl-CoA fluctuations (Cai
et al., 2011). Therefore, we suspected that the Gcn5p acetyl-
transferase might also catalyze the acetylation of Ifh1p. We
confirmed that Ifh1p was no longer acetylated in strains lacking
Gcn5p (Figure 3A). Then, we deleted several candidate deacety-
lases to determine which of them might regulate Ifh1p acetyla-
tion. Surprisingly, Rpd3p, the histone deacetylase known to
regulate the transcription of RP and ribi genes (Huber et al.,
2011) and the opening of rDNA repeats (Sandmeier et al.,
2002), was not responsible for Ifh1p deacetylation. Instead, the
deletion of the NAD+-dependent deacetylase SIR2 resulted in(I) The Ifh1p 39K/Q acetylatedmimicmutant is more stable during nutrient depletio
on the growth curve. Ifh1p levels decrease as cells grow to a higher density appro
K/Q mutant. The membrane was stained by Ponceau S and shown as a loading
(J) sir2D and sir2Dhst1D mutants exhibit increased Ifh1p stability. Experiments
seems to be more stable in the mutants where it is highly acetylated. Two differe
See also Figure S4.
Cell Rethe increased acetylation of Ifh1p (Figure 3A). Deletion of
HST1, the closest SIR2 homolog, in combination with sir2D
further increased Ifh1p acetylation, suggesting that these deace-
tylases are primarily responsible for Ifh1p deacetylation (Fig-
ure 3A). To further clarify the contribution of SIR2 as well as the
HST genes, we compared single deletion mutants as well as
double deletion mutants combining SIR2 deletion with different
HST gene deletions. These data indicate that Sir2p is the primary
deacetylase for Ifh1p. However, in the absence of Sir2p, Hst1p
and Hst2p can also contribute to the deacetylation of Ifh1p
(Figures 3B and 3C). Thus, Ifh1p is a significant nonhistone sub-
strate of sirtuins in budding yeast.
Next, we mapped the acetylation sites on Ifh1p. The amino
acid sequence composition of Ifh1p contains many clusters of
basic and acidic residues that impose difficulty for proteomic
analysis (Figure S3). Therefore, we sought an alternative
approach by inducing peptide cleavage at cysteine residues
after cyanylation (Tu and Wang, 1999). Fortuitously, Ifh1p con-
tains only two endogenous cysteine residues (Figure 3D), and
mutating them to serine did not affect cell growth. We performed
the mapping experiments with C-terminally FLAG-tagged Ifh1p
immunoprecipitated from cells grown to log phase, conditions
under which the protein is heavily acetylated. When the wild-
type protein was cleaved at C580 and C665, peptide fragments
C-terminal to the cleavage sites were recognized by a FLAG
antibody. However, they ran at different sizes in comparison
the peptides recognized by an acetyl-lysine (acK) antibody,
suggesting that the acetylated sites are N-terminal to C580
(Figure 3E).
In a C580S/C665S Ifh1p mutant strain background, serine-to-
cysteine mutations were introduced at various sites before resi-
due 580 in order to induce peptide cleavage. The pattern of
peptides recognized by FLAG antibody was compared to those
recognized by acK antibody in order to deduce the acetylated re-
gion within Ifh1p. To map additional sites possibly acetylated
upon cycloheximide treatment (Figure 2F), we also included a
set of cycloheximide-treated cells in the experiment. The pep-
tides generated by cleavage at amino acid (aa) 189 were the
same size in both blots, whereas peptides generated by cleav-
age at aa 297 were different sizes. Thus, the acetylated sites
were most likely present between aa 189 and aa 297 (Figure 3F).
However, mutating the 18 lysines within this region to arginine
decreased but did not abolish acetylation of Ifh1p, indicating
that there are additional lysines that can be modified (Figure 3G).
It remained possible that the cleavage fragment N-terminal to
aa 189 was also acetylated but masked by the light chain after
SDS-PAGE and western analysis. We mutated 21 additional
lysine residues to arginine between aa 1–189. This mutant ex-
hibited no detectable acetylation signal with or without cyclohex-
imide treatment (Figure 3H). The K/Q acetylated mimic mutant
was also made (Figure 3H). Although 39 lysines in this essentialn. Lysateswere prepared from the indicated strains at the indicated time points
aching stationary phase. Levels of Ifh1p are lower in K/R mutant and higher in
control. Two different exposures of the same blot are shown.
were performed as described above with sir2D and sir2Dhst1D strains. Ifh1p
nt exposures of the same blot are shown.
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protein were mutated, no obvious growth phenotypes were
observed when either the 39K/R or 39K/Q mutants were tested
under a variety of conditions (Figure S4A).
We observed that the acetylation of Ifh1p decreased prior to a
decrease in its protein levels as cells entered stationary phase
(Figure 2E), suggesting that acetylation regulates its protein sta-
bility and half-life. To measure the stability of Ifh1p, we avoided
using protein synthesis inhibitors such as cycloheximide
because they can induce TORC1 signaling and the acetylation
of Ifh1p (Figure 2F), thereby confounding interpretation of the
results. Instead, we measured Ifh1p levels in cells growing
from a low to high density in SD medium. Lower levels of Ifh1p
were detected in the acetylation-defective 39K/R mutant,
whereas higher levels of Ifh1p were detected in the acetylated
mimic 39K/Q mutant despite there being no differences in
growth rate (Figure 3I). Consistent with these findings, sirtuin
deletion mutants that harbor increased acetylated Ifh1p also ex-
hibited increased protein levels of Ifh1p, supporting the idea that
Ifh1p stability is regulated by nutrient-responsive acetylation in
its N-terminal region (Figure 3J).
Then, we tested whether the 39K/R and 39K/Q mutants re-
sulted in any phenotypes related to growth or ribosomal gene
transcription. The expression of RP genes, induction of RP
genes in response to acetyl-CoA, and recruitment of Ifh1p to
RP genes were not compromised in these mutants (Figures
S4D and S4F). We also checked the expression of several non-
RP Ifh1p target genes identified from the ChIP-seq experiment
(Figure 1), but their levels remained similar in mutants in compar-
ison to wild-type (WT) cells (Figure S4G). Moreover, these
mutants exhibited similar growth and regrowth rates on a variety
of carbon sources (Figures S4A and S4E) as well as chronolog-
ical lifespan (Figure S4B). Thus, despite the effects on Ifh1p
stability, we did not observe any significant growth phenotype
in acetylation site mutants of Ifh1p.
Ifh1p Is Phosphorylated by PKA at S969
Tomap the phosphorylation sites on Ifh1p, we used the same set
of cysteine substitution mutants to deduce the general region of
phosphorylation after peptide cleavage. The pattern of peptides
recognized by both the FLAG antibody and phospho-PKA sub-
strate antibody matched very well, suggesting that the phos-
phorylation site(s) lie C-terminal to C580 (Figure 4A). Then, we
searched the C-terminal sequence of Ifh1p for PKA phosphory-
lationmotifs (RRXS/T) and constructed single S/A or T/Amutants
for each of the five sites that were identified. One single mutation
converting S969 to A was sufficient to eliminate the signal
recognized by the phospho-PKA substrate antibody (Figure 4B).
Using this phosphorylation mutant and the acetylation mutants
described above, we also observed that Ifh1p acetylation and
phosphorylation modifications could occur independent of
each other (Figure S4H).
Next, we tested whether S969 was phosphorylated by PKA
using a tpk1as tpk2as tpk3as strain that expressed modified PKA
alleles that are sensitive to the ATP analog 1NM-PP1 (Zaman
et al., 2009). Upon treatment with 1NM-PP1, Ifh1p phosphoryla-
tion disappeared within 10 min, suggesting that it is indeed a
PKA substrate (Figure 4C). Because Sch9p substrates share
the same motif as PKA substrates, we also tested Ifh1p phos-1068 Cell Reports 4, 1063–1071, September 26, 2013 ª2013 The Auphorylation in a sch9D strain; however, no alteration of Ifh1p
phosphorylation was observed (Figure S4I). These data show
that PKA phosphorylates Ifh1p on S969 as cells enter growth.
To test the functional role of Ifh1p phosphorylation, we con-
structed S969A and S969D mutants and observed that they
did not exhibit any obvious growth defects under a variety of
nutrient conditions (Figure S4A). We also did not observe any
significant phenotypes when subjecting these mutants to the
same series of assays as the acetylation site mutants (Figures
S4B–4G). Furthermore, mutation of acetylated sites in combina-
tion with the phosphorylated site also did not result in any sub-
stantial phenotype under the conditions tested.
Nutrient-Responsive Posttranslational Modifications of
Ifh1p Impact Replicative Lifespan
Interestingly, the posttranslational modifiers of Ifh1p—PKA,
TORC1, and Sir2p—have each been implicated in the regulation
of replicative lifespan (RLS) in budding yeast (Longo et al., 2012).
Moreover, downstream targets of Ifh1p, such as RP subunits
and GCN4, have also been linked to lifespan regulation (Steffen
et al., 2008). Therefore, we tested whether mutations in the acet-
ylated or phosphorylated sites of Ifh1p might also impact RLS.
The acetylation site mutants of Ifh1p exhibited a modestly
shorter RLS in comparison to the WT control. Notably, the single
S969A mutant that cannot be phosphorylated exhibited a signif-
icantly increased RLS (30%–40%) (Figure 4D). However, the RLS
of the S969D phosphomimetic mutant remained comparable to
WT. Deletion of GCN4,which has been shown to be required for
RLS extension triggered by 60S ribosomal subunit depletion
(Steffen et al., 2008), did not affect RLS extension by the Ifh1p
S/A mutant (Figure 4D). This modification of Ifh1p also did not
affect GCN4 expression levels (Figure S4G). Moreover, the S/A
mutant was still able to extend RLS in a strain lacking TOR1 (Fig-
ure 4D). However, the substantial RLS extension observed in the
S/A mutant was entirely dependent on Sir2p (Figure 4D). The
dependency on Sir2p is not surprising, given that the deletion
of SIR2 was observed to prevent lifespan extension in many
long-lived yeast mutants (Delaney et al., 2011). Altogether, these
data indicate that inhibiting the PKA-regulated phosphorylation
of Ifh1p via mutation of a single site is sufficient to significantly
increase RLS to an extent comparable to calorie restriction
mimetic mutants (Kaeberlein et al., 2005). Thus, this nutrient-
responsive phosphorylation modification on Ifh1p is involved in
the regulation of cellular replicative potential as opposed to the
regulation of rates of RP gene transcription.
DISCUSSION
Although ribosomebiogenesis is recognized as a key component
of the cellular growth program, much remains unclear regarding
how this fundamental process is coordinated with nutrient avail-
ability and metabolic state. In this study, we sampled highly syn-
chronized cells across different growth states in the YMC to
discover that an essential transcription factor, Ifh1p, involved in
ribosomal gene transcription is subject to regulation by multiple
nutrient-responsive, posttranslational modifications.
We also characterized the genome-wide occupancy of
Ifh1p using the YMC. These ChIP-seq experiments provide athors
Figure 4. Ifh1p Is Phosphorylated on S969 by PKA in Order to Regulate Replicative Lifespan
(A) Ifh1p is phosphorylated at site(s) C-terminal of C580. On the basis of the mapping method described above, the exact match of FLAG and RRXS*/T* blotting
patterns indicates the phosphorylated sites are after residue 580.
(B) Ifh1p is phosphorylated at S969. Candidate sites that match themotif RRXS*/T* weremutated to alanine.Mutation at S969 eliminated the signal recognized by
the phospho-specific antibody.
(C) Ifh1p is phosphorylated by PKA. In an engineered strain (tpk1astpk2astpk3as) where PKA is rendered specifically sensitive to the inhibitor 1NM-PP1,
phosphorylation of Ifh1p is eliminated within 10 min of treatment with 1NM-PP1.
(D) Nutrient-responsive phosphorylation of Ifh1p impacts RLS. The30%–40% increase in RLS of the S969A mutant was dependent on Sir2p, but not Gcn4p or
Tor1p. Numbers in parentheses denote average lifespan and number of cells tested. Table S2 contains statistical analysis of the RLS data.
See also Figure S4.higher-resolution profile of Ifh1p occupancy in the genome and
reveal additional important targets aside from RP genes. Several
translation elongation factors were bound by Ifh1p, suggesting
that their transcription may be regulated by Ifh1p. Moreover,
GCN4, a transcriptional activator of amino acid biosynthetic
genes (Hinnebusch, 2005), is also a target, suggesting that
Ifh1p regulates the supply of amino acids for protein translation.
Ifh1p is dynamically acetylated by the Gcn5p-containing
SAGA complex, specifically during growth. Gcn5p has the
unique ability to acetylate its substrates in tune with acetyl-
CoA levels (Cai et al., 2011), enabling the acetyltransferase to
coordinate the acetylation of its targets in tunewith themetabolicCell Restate of a cell. Upon entry into growth, acetyl-CoA drives the
acetylation of histones present at a set of over 1,000 growth
genes, which include virtually all RP and ribi genes (Cai et al.,
2011). The dynamic acetylation of Ifh1p coincides with the acet-
ylation of histones and subunits within SAGA, suggesting that
these substrates are all subjected to the same acetyl-CoA-
regulated acetylation mechanism used to coordinate cell growth
with this important intermediate in energy metabolism.
Ifh1p is rapidly deacetylated as cells transition out of the
growth phase. Interestingly, the deacetylation of Ifh1p is
catalyzed by NAD+-dependent sirtuins instead of non-NAD+-
dependent deacetylases such as Rpd3p. When carbon sourcesports 4, 1063–1071, September 26, 2013 ª2013 The Authors 1069
become limiting, acetyl-CoA levels decrease along with Gcn5p
activity, and the activity of NAD+-dependent deacetylases may
then predominate. Therefore, this transcriptional coactivator is
subjected to a competition between acetyl-CoA-regulated acet-
ylation and NAD+-dependent deacetylation that can be tipped in
either direction by changes in metabolic state. Furthermore, our
studies establish Ifh1p as a significant nonhistone substrate of
Sir2p in yeast, and up to 39 lysine residues in its N-terminal re-
gion can be deacetylated.
Ifh1p is also dynamically phosphorylated by PKA. Both the
phosphorylation and acetylation of Ifh1p are inhibited by rapa-
mycin, suggesting that TORC1 is also a key regulator of Ifh1p.
Previous studies implicated TORC1 and PKA signaling in the
regulation of Crf1p, a repressor of RP gene transcription (Martin
et al., 2004). TORC1 and PKA activation result in the dephos-
phorylation of Crf1p and its confinement to the cytosol. Upon
the inactivation of TORC1, Crf1p becomes phosphorylated and
nuclear, leading to the repression of RP genes. Furthermore,
TORC1 and PKA inactivate repressors of ribi genes such as
Dot6p and Tod6p (Huber et al., 2011; Lippman and Broach,
2009). Stb3p, a repressor of rRNA processing genes, is also in-
activated by TORC1 and glucose (Huber et al., 2011; Liko
et al., 2010). We show that Ifh1p is yet another ribosomal tran-
scription factor that is exposed to phosphorylation by TORC1
and PKA signaling.
The consequences of mutations in the acetylated or phos-
phorylated sites in Ifh1p on cell growth appear extremely modest
despite the fact that the protein is essential. We did not observe
significant growth defects for the 39K/R, 39K/Q, S969A, or
S969D mutants, nor did we find any differences in their ability
to bind RP gene promoters or activate RP genes (Figure S4).
Although the 39K/R mutant decreased the overall Ifh1p levels
in the cell, there is apparently still sufficient Ifh1p to achieve
normal levels of RP gene transcription. Ifh1p has a very peculiar
protein sequence that containsmany clusters of acidic and basic
residues but lacks any defined domains (Figure S3). We predict
that it acts as a scaffold in order to bring together numerous
other factors for enabling the activation of RP genes. The
dynamicmodifications within Ifh1pmight also be a consequence
of its proximity to other macromolecules that are subjected
to nutrient-responsive regulation (e.g., the acetyl-CoA-driven
acetylation of histones at RP genes catalyzed by SAGA and
the phosphorylation-dependent regulation of Crf1p localization
by TORC1 and PKA). Moreover, cycloheximide treatment signif-
icantly increased both the phosphorylation and acetylation of
Ifh1p, suggesting that these modifications stimulate Ifh1p and
possibly other RP transcription factors under conditions of trans-
lation stress that could be frequently encountered in the wild in
the face of unpredictable nutrient availability.
Finally, it is both interesting and unexpected that the nutrient-
responsive phosphorylation of Ifh1p instead appears to function
primarily in the regulation of replicative lifespan. A single muta-
tion preventing Ifh1p phosphorylation was sufficient to extend
RLS in a manner comparable to mutations in the TORC1-Sch9
and PKA signaling pathways that mimic caloric restriction. The
fact that this Ifh1p modification specifically impacts RLS, but
not apparent rates of RP gene transcription and cell growth, sup-
ports the existence of a specific cellular mechanism for weighing1070 Cell Reports 4, 1063–1071, September 26, 2013 ª2013 The Aureplicative potential that is separable from the overall growth rate
of the cell. Thus, future work will be required in order to decipher
the specific mechanism by which the phosphorylation of this
ribosomal gene transcription factor functions in response to
nutrients to limit the replicative potential of yeast cells.
EXPERIMENTAL PROCEDURES
Antibodies
Anti-acetyl-lysine (ST1027, Calbiochem) and anti-phospho-PKA substrate
(RRXS*/T*; 100G7E, Cell Signaling Technology) were used for the detection
of acetylation and phosphorylation on Ifh1p. FLAG antibody (M2, Sigma-
Aldrich) was used for western blotting, immunoprecipitation, and ChIP with
IFH1-FLAG cells.
Chromatin Immunoprecipitation
ChIP was performed according to a well-established protocol with minor
modifications (Ezhkova and Tansey, 2006). Lysates were sonicated with a
Bioruptor, precleared, and incubated with 2 mg FLAG M2 antibody overnight.
After washes, DNAwas recovered and purified. Real-time PCRwas performed
in triplicate with SYBR green reagents (Applied Biosystems). PCR primers
were designed with Primer Express (Applied Biosystems).
ChIP-Seq
Library construction was performed using a protocol from the following web-
site: http://bioinfo.mbb.yale.edu/array/Solexa_LibraryPrep_20080229ge.pdf.
Sequencing was performed on an Illumina GA IIX supervised by the University
of Texas Southwestern Microarray Core Facility. The data were assembled to
the reference genome by Bowtie and analyzed by CisGenome as described in
its online tutorial (Ji et al., 2008). Peaks were annotated with the gene whose
transcription start site is closest to the peak region. CisGenome was used to
visualize ChIP-seq peaks.
Yeast Strains and Methods
Deletion strains and tagged strains were made by homologous recombination
followed by drug selection (Longtine et al., 1998). Site-directed mutagenesis
was performed by PCR in which primers containing the mutation were used
to generate two PCR fragments that contain 45 bp overlapping regions con-
taining the mutation. Fusion PCR was performed to anneal two fragments
together, and the product was used for transformation. Synthesized templates
were used for constructing 18K/R, 39K/R, and 39K/Q mutants. All strains are
listed in Table S3. The CEN.PK background was used in most experiments
except for the RLS assays.
Yeast Cell Lysis and Immunoprecipitation
Typically, 100 OD yeast cells were lysed in 1 ml lysis buffer (100 mM Tris-Cl
[pH 7.5], 100 mM NaCl, 50 mM NaF, 1 mM EDTA, 1 mM EGTA, 0.1% Tween-
20, 10% glycerol, 50 mM sodium butyrate, 50 mM nicotinamide, 5 mM trichos-
tatin A, 1 mM PMSF, 10 mM leupeptin, 5 mM pepstatin A, Roche protease
inhibitor cocktail, and 14mM b-mercaptoethanol) by bead beating, and immu-
noprecipitation was performed by incubating the lysate with 15 ml magnetic
beads (Invitrogen) conjugated to 2 mg FLAGM2 antibody (Sigma-Aldrich). After
being washed three times in the same buffer, the beads were boiled in order to
release the precipitated proteins for western blot analysis.
Mapping by Cleavage at Cyanylated Cysteines
Immunoprecipitated Ifh1p bound to magnetic beads was resuspended in
reaction buffer (0.1 M Tris acetate [pH 8.0] and 8 M GnCl). Then, 2-nitro-5-
thiocyanobenzoic acid was added to 1 mM, and the reaction was incubated
at room temperature for 30 min. Sodium hydroxide was added in order to
adjust the pH to 9.0, and the reaction was incubated at 37C overnight. The
reaction was boiled and run on a 3%–8% Tris acetate precast gel.
Lifespan Assays
RLS assays were carried out as described previously (Steffen et al., 2009).
Unless otherwise noted, all lifespan experiments were performed on yeastthors
extract-peptone-dextrose growth medium plates with 2% glucose. The BY
strain background was used for RLS assays.
ACCESSION NUMBERS
The wig files for the ChIP-seq tracks shown in Figure 1 have been deposited
into the NCBI Gene Expression Omnibus and are available at accession
number GSE39147.
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